Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of PLP1 protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PLP1 mRNA | affects expression | 16483693
|
D001151 |
Arsenic |
Arsenic results in decreased expression of PLP1 mRNA | decreases expression | 19654921
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of PLP1 mRNA | decreases expression | 20106945
|
D003024 |
Clozapine |
Clozapine results in decreased expression of PLP1 mRNA | decreases expression | 18797397
|
D003024 |
Clozapine |
Clozapine results in increased expression of PLP1 mRNA | increases expression | 17266109
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of PLP1 mRNA | increases expression | 18042831
|
D005047 |
Etoposide |
PLP1 protein affects the susceptibility to Etoposide | affects response to substance | 16217747
|
D006220 |
Haloperidol |
Haloperidol results in decreased expression of PLP1 mRNA | decreases expression | 18797397 17177202
|
D008466 |
Mechlorethamine |
Mechlorethamine results in decreased expression of PLP1 mRNA | decreases expression | 17107856
|
D016685 |
Mitomycin |
PLP1 protein affects the susceptibility to Mitomycin | affects response to substance | 16217747
|
C076029 |
olanzapine |
olanzapine results in decreased expression of PLP1 mRNA | decreases expression | 18797397
|
C041786 |
palm oil |
palm oil results in increased expression of PLP1 mRNA | increases expression | 18042831
|
D010622 |
Phencyclidine |
Phencyclidine results in increased expression of PLP1 mRNA | increases expression | 17266109
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of PLP1 mRNA | decreases expression | 20106945
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.93 | 14514962 11752688 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.64 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.00 | 20464547 20127859 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.68 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.46 | 16835633 |
MESH:D018246 |
Adrenocortical Adenoma |
|
Arsenic |
5.31 | 17306315 |
MESH:D000380 |
Agranulocytosis |
|
Clozapine |
5.13 | 14617031 12649775 16160616 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.00 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.15 | 19183758 |
MESH:D020261 |
Arsenic Poisoning |
|
Arsenic |
2.88 | 18414634 16835338 16251483 12569548 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.96 | 15238619 |
MESH:D050197 |
Atherosclerosis |
|
Arsenic |
3.28 | 19371607 12928151 |
MESH:D001321 |
Autistic Disorder |
|
Haloperidol |
2.84 | 18080171 19368416 |
MESH:D001321 |
Autistic Disorder |
|
olanzapine |
2.84 | 17069543 18685284 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.10 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.89 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.80 | 15746008 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Etoposide |
5.26 | 14601052 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.97 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
1.97 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Etoposide |
1.97 | 16322251 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.97 | 20435547 |
MESH:D002057 |
Burns, Chemical |
|
Mechlorethamine |
6.33 | 9625245 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.84 | 16835633 |
MESH:D002280 |
Carcinoma, Basal Cell |
|
Arsenic |
3.62 | 17687452 15504454 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
3.25 | 12619106 21507988 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Arsenic |
3.25 | 16507464 17306315 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Arsenic |
4.76 | 18922899 17687452 15504454 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.76 | 20419170 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Arsenic |
4.13 | 18640142 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.39 | 16120746 18670907 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Arsenic |
3.48 | 19152805 17938729 15738583 |
MESH:D002340 |
Carotid Artery Diseases |
|
Arsenic |
4.36 | 18022660 16973168 |
MESH:D002375 |
Catalepsy |
|
Haloperidol |
4.99 | 1977408 15215559 |
MESH:D002389 |
Catatonia |
|
olanzapine |
6.35 | 16772815 18071103 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.21 | 16835633 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.12 | 16354765 15340226 12621046 15668235 8697196 |
MESH:D003072 |
Cognition Disorders |
|
Clozapine |
5.04 | 17123785 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.11 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 20055451 10048152 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
Haloperidol |
4.90 | 20210726 |
MESH:D003704 |
Dementia |
|
Haloperidol |
4.63 | 11575062 |
MESH:D002658 |
Developmental Disabilities |
|
olanzapine |
4.73 | 17069543 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Clozapine |
4.55 | 16402076 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.55 | 17107852 |
MESH:D006970 |
Disorders of Excessive Somnolence |
|
Clozapine |
5.65 | 15331141 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.55 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.80 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Clozapine |
8.99 | 16402076 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
8.99 | 18367378 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.43 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.00 | 18230668 16714409 15322242 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.07 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.02 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.05 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
3.29 | 18296743 17967931 19551842 19004024 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.53 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
8.87 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.87 | 20067830 |
MESH:D005534 |
Foot Diseases |
|
Arsenic |
5.66 | 6392382 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.69 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.54 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.54 | 10048152 11294989 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.39 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.96 | 15340226 16120746 12621046 |
MESH:D006561 |
Herpes Simplex |
|
Etoposide |
4.64 | 10809021 |
MESH:D006689 |
Hodgkin Disease |
|
Etoposide |
3.92 | 16135485 17606976 16200630 18180244 15147373 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.14 | 15340226 8697196 16959395 16354765 18606429 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.65 | 21332399 |
MESH:D017488 |
Hyperkeratosis, Epidermolytic |
|
Arsenic |
4.51 | 17050553 |
MESH:D006948 |
Hyperkinesis |
|
Clozapine |
4.99 | 16046005 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.67 | 21332399 |
MESH:D006963 |
Hyperphagia |
|
olanzapine |
6.31 | 17933447 |
MESH:D006973 |
Hypertension |
|
Arsenic |
5.29 | 11953799 16076760 9931084 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.29 | 18670907 18850075 |
MESH:D006987 |
Hypesthesia |
|
Arsenic |
5.66 | 16093927 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
5.00 | 20412841 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.00 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
3.14 | 11836018 18457598 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.39 | 16580747 |
MESH:D007642 |
Keratosis |
|
Arsenic |
5.07 | 12749816 16930632 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Arsenic |
3.59 | 17339181 |
MESH:D008064 |
Lipidoses |
|
Clozapine |
4.00 | 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.90 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Arsenic |
2.55 | 11134558 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
14.47 | 9163691 18177683 2125692 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Arsenic |
14.47 | 16368122 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
14.47 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Mitomycin |
14.47 | 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.47 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
5.91 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.91 | 12151625 |
MESH:D008133 |
Long QT Syndrome |
|
olanzapine |
4.77 | 20210726 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
4.89 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Arsenic |
4.89 | 17976673 17306315 19168569 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.89 | 20869020 18816296 18520028 17053015 6695378 20464547 18569708 20064080 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.89 | 11884234 19555203 |
MESH:D008223 |
Lymphoma |
|
Etoposide |
3.96 | 12854902 12556972 |
MESH:D001523 |
Mental Disorders |
|
Clozapine |
13.95 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
Haloperidol |
13.95 | 16856516 |
MESH:D001523 |
Mental Disorders |
|
olanzapine |
13.95 | 16856516 |
MESH:D008659 |
Metabolic Diseases |
|
olanzapine |
5.44 | 19142110 |
MESH:D024821 |
Metabolic Syndrome X |
|
Clozapine |
4.46 | 19142101 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.23 | 16381670 |
MESH:D017202 |
Myocardial Ischemia |
|
Arsenic |
9.15 | 15371236 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
9.15 | 12213967 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
2.19 | 11141357 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.28 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Arsenic |
3.49 | 16620997 |
MESH:D020078 |
Neurogenic Inflammation |
|
Arsenic |
4.43 | 17056641 |
MESH:D009765 |
Obesity |
|
Clozapine |
7.80 | 18515891 19142110 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
7.80 | 19632207 17217161 18457598 11836018 16723640 21332399 18674790 20132043 20518802 |
MESH:D009765 |
Obesity |
|
olanzapine |
7.80 | 18515891 |
MESH:D010051 |
Ovarian Neoplasms |
|
Arsenic |
2.76 | 17306315 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Etoposide |
5.98 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Mitomycin |
5.98 | 15113037 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.35 | 12520081 |
MESH:D020371 |
Pelizaeus-Merzbacher Disease |
marker/mechanism |
|
| |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Arsenic |
4.24 | 16093927 |
MESH:D016491 |
Peripheral Vascular Diseases |
|
Arsenic |
5.07 | 6392382 15371236 16905509 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.62 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.27 | 11118676 11399792 11896295 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
Arsenic |
2.68 | 16140617 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.68 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Etoposide |
2.68 | 17172428 |
MESH:D011507 |
Proteinuria |
|
Arsenic |
4.06 | 21343184 |
MESH:D011595 |
Psychomotor Agitation |
|
Haloperidol |
12.06 | 11575062 |
MESH:D011595 |
Psychomotor Agitation |
|
olanzapine |
12.06 | 18685284 |
MESH:D011618 |
Psychotic Disorders |
|
Clozapine |
9.29 | 15331141 |
MESH:D011618 |
Psychotic Disorders |
|
Haloperidol |
9.29 | 11575062 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.90 | 18990726 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Etoposide |
4.77 | 14601052 |
MESH:D012559 |
Schizophrenia |
|
Clozapine |
5.95 | 20452607 20521320 20580759 17667964 20107430 20168265 11763009 11151749 20521326 16141801 18855531 17123785 17726453 18806925 19369910 |
MESH:D012559 |
Schizophrenia |
|
Haloperidol |
5.95 | 20107430 18513383 1830565 19369910 |
MESH:D012559 |
Schizophrenia |
|
olanzapine |
5.95 | 17726453 20107430 20521326 |
MESH:D012871 |
Skin Diseases |
|
Arsenic |
2.76 | 16353154 19834688 15952646 18709164 17938729 16759981 16702368 17548696 6392382 17453740 17050553 |
MESH:D012878 |
Skin Neoplasms |
|
Arsenic |
9.58 | 16251483 15504454 17050553 19538983 17976673 17029826 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
9.58 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.58 | 16192470 |
MESH:C536857 |
Spastic paraplegia 2, X-linked |
marker/mechanism |
|
| |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
1.56 | 2093021 20155912 |
MESH:D017180 |
Tachycardia, Ventricular |
|
Haloperidol |
11.17 | 20210726 |
MESH:D017180 |
Tachycardia, Ventricular |
|
olanzapine |
11.17 | 20210726 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.00 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Arsenic |
5.23 | 17976673 19322015 19429237 11144890 18640142 17306315 15987713 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
5.23 | 17053015 |
MESH:D014652 |
Vascular Diseases |
|
Arsenic |
4.82 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.69 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.35 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Clozapine |
16.71 | 17502770 20521320 16402076 16141801 20564506 20107430 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
16.71 | 16723640 |
MESH:D015430 |
Weight Gain |
|
olanzapine |
16.71 | 20107430 17933447 19434072 |
MESH:D015431 |
Weight Loss |
|
Clozapine |
5.16 | 17933447 |